N/A
Completed N=27
A Mobile Tai Chi Platform for Fall Prevention in Older Adults - Phase II
Source: ClinicalTrials.gov NCT05006261 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcomePrimary: Protocol Adherence — 76.81 percentage of session completed
Summary
This is a single-arm longitudinal feasibility study for older adults that involves a 12-week home-based Tai Chi program and includes four remote and/or in-person data collection visits. The investigators will collect additional clinical data in a subset of participants who agree to undergo additional assessments in the Motion Analysis Laboratory at the Spaulding Rehabilitation Hospital in Boston, MA during two in-person data collection sessions. The investigators will assess feasibility and acceptability of the Tele-Tai Chi intervention; explore changes in clinically relevant outcome measures including: physical activity, self-efficacy, quality of life, balance, and gait; and evaluate longitudinal changes in Tai Chi proficiency.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Protocol Adherence |
76.81 | — |
| PRIMARY Retention |
100 | — |
| PRIMARY System Usability Scale |
87.18 | — |
Eligibility Criteria
Inclusion Criteria
- Men and women between 60 and 85 years old
- TC naïve (i.e., never practiced TC)
- Self-reported ability to walk continuously for 15 minutes without an assistive device
- Working email address
- Prior experience with and current access to a computer, smart phone or tablet device
Exclusion Criteria
- Chronic neuromuscular conditions (e.g. Parkinson's disease, multiple sclerosis, stroke)
- Acute medical conditions requiring hospitalization within the past 6 months or that could interfere with the ability of prospective volunteers to safely participate in the study
- Active cancer
- Significant musculoskeletal conditions requiring chronic use of pain medication
- Cognitive impairment (Diagnosed with dementia (self-reported), or Montreal Cognitive Assessment (MoCA)-Blind score < 18)
Data sourced from ClinicalTrials.gov (NCT05006261). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.